Ulrike Gnad-Vogt
Direttore Tecnico/Scientifico/R&S presso CureVac SE
Posizioni attive di Ulrike Gnad-Vogt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 | - |
Storia della carriera di Ulrike Gnad-Vogt
Precedenti posizioni note di Ulrike Gnad-Vogt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CUREVAC N.V. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 | 01/01/2019 |
| Corporate Officer/Principal | 01/01/2019 | - |
Formazione di Ulrike Gnad-Vogt
| Universität des Saarlandes | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Ulrike Gnad-Vogt
- Esperienza
